The effect of prone positioning on maternal haemodynamics and fetal wellbeing in the third trimester-A primary cohort study with a scoping review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 12 06 2023
accepted: 25 08 2023
medline: 1 11 2023
pubmed: 11 10 2023
entrez: 11 10 2023
Statut: epublish

Résumé

Supine sleep position is associated with stillbirth, likely secondary to inferior vena cava compression, and a reduction in cardiac output (CO) and uteroplacental perfusion. Evidence for the effects of prone position in pregnancy is less clear. This study aimed to determine the effect maternal prone position on maternal haemodynamics and fetal heart rate, compared with left lateral position. Twenty-one women >28 weeks' gestation underwent non-invasive CO monitoring (Cheetah) every 5 minutes and continuous fetal heart rate monitoring (MONICA) in left lateral (20 minutes), prone (30 minutes), followed by left lateral (20 minutes). Anxiety and comfort were assessed by questionnaires. Regression analyses (adjusted for time) compared variables between positions. The information derived from the primary study was used in an existing mathematical model of maternal circulation in pregnancy, to determine whether occlusion of the inferior vena cava could account for the observed effects. In addition, a scoping review was performed to identify reported clinical, haemodynamic and fetal effects of maternal prone position; studies were included if they reported clinical outcomes or effects or maternal prone position in pregnancy. Study records were grouped by publication type for ease of data synthesis and critical analysis. Meta-analysis was performed where there were sufficient studies. Maternal blood pressure (BP) and total vascular resistance (TVR) were increased in prone (sBP 109 vs 104 mmHg, p = 0.03; dBP 74 vs 67 mmHg, p = 0.003; TVR 1302 vs 1075 dyne.s-1cm-5, p = 0.03). CO was reduced in prone (5.7 vs 7.1 mL/minute, p = 0.003). Fetal heart rate, variability and decelerations were unaltered. However, fetal accelerations were less common in prone position (86% vs 95%, p = 0.03). Anxiety was reduced after the procedure, compared to beforehand (p = 0.002), despite a marginal decline in comfort (p = 0.04).The model predicted that if occlusion of the inferior vena cava occurred, the sBP, dBP and CO would generally decrease. However, the TVR remained relatively consistent, which implies that the MAP and CO decrease at a similar rate when occlusion occurs. The scoping review found that maternal and fetal outcomes from 47 included case reports of prone positioning during pregnancy were generally favourable. Meta-analysis of three prospective studies investigating maternal haemodynamic effects of prone position found an increase in sBP and maternal heart rate, but no effect on respiratory rate, oxygen saturation or baseline fetal heart rate (though there was significant heterogeneity between studies). Prone position was associated with a reduction in CO but an uncertain effect on fetal wellbeing. The decline in CO may be due to caval compression, as supported by the computational model. Further work is needed to optimise the safety of prone positioning in pregnancy. This trial was registered at clinicaltrials.gov (NCT04586283).

Identifiants

pubmed: 37819872
doi: 10.1371/journal.pone.0287804
pii: PONE-D-23-13525
pmc: PMC10566740
doi:

Banques de données

ClinicalTrials.gov
['NCT04586283']

Types de publication

Review Meta-Analysis Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0287804

Informations de copyright

Copyright: © 2023 Ormesher et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

Karli Buchling is the inventor of the Anna Cushion and is the Founder of Natal Comfort who market the cushion. She applied for the research funding with Professor Heazell, but had no part in the conduct of the experiments or analysis of the data. This does not alter our adherence to PLoS One policies on sharing data and materials.

Références

J Matern Fetal Neonatal Med. 2019 Dec;32(23):3923-3930
pubmed: 29772936
BMC Pregnancy Childbirth. 2018 Nov 16;18(1):445
pubmed: 30445912
Chiropr Osteopat. 2007 Nov 28;15:19
pubmed: 18045493
Am J Physiol Regul Integr Comp Physiol. 2002 Jul;283(1):R174-80
pubmed: 12069943
Br J Anaesth. 2012 Dec;109(6):950-6
pubmed: 23059960
Intensive Care Med Exp. 2023 Apr 3;11(1):15
pubmed: 37009935
BMJ Evid Based Med. 2018 Apr;23(2):60-63
pubmed: 29420178
Eur J Appl Physiol. 2011 Feb;111(2):163-74
pubmed: 20857139
Acta Obstet Gynecol Scand. 2020 May;99(5):631-636
pubmed: 31856296
Obstet Gynecol. 2015 Feb;125(2):347-355
pubmed: 25568999
Int J Gynaecol Obstet. 2013 Jun;121(3):261-5
pubmed: 23507553
PLoS One. 2017 Jun 13;12(6):e0179396
pubmed: 28609468
Int J Numer Method Biomed Eng. 2021 Nov;37(11):e3267
pubmed: 31799783
Am J Obstet Gynecol. 1984 Mar 15;148(6):764-71
pubmed: 6702946
Int J Numer Method Biomed Eng. 2017 Jul;33(7):
pubmed: 27709800
Biomech Model Mechanobiol. 2019 Aug;18(4):1155-1176
pubmed: 30838498
Arch Dis Child. 1990 Jan;65(1 Spec No):39-43
pubmed: 2306133
Clinics (Sao Paulo). 2017 Jun;72(6):325-332
pubmed: 28658431
BMJ. 2011 Jun 14;342:d3403
pubmed: 21673002
J Physiol. 2017 Dec 15;595(24):7441-7450
pubmed: 29023736
BJOG. 2018 Jan;125(2):254-262
pubmed: 29152887

Auteurs

Laura Ormesher (L)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, United Kingdom.

Jessica Catchpole (J)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Linda Peacock (L)

Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, United Kingdom.

Heather Pitt (H)

Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, United Kingdom.

Anastasia Fabian-Hunt (A)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Dexter Hayes (D)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Claudia Popp (C)

Department of Biomedical Engineering, Faculty of Science and Engineering, Swansea University, Swansea, United Kingdom.

Jason M Carson (JM)

Department of Biomedical Engineering, Faculty of Science and Engineering, Swansea University, Swansea, United Kingdom.

Raoul van Loon (R)

Department of Biomedical Engineering, Faculty of Science and Engineering, Swansea University, Swansea, United Kingdom.

Lynne Warrander (L)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

Karli Büchling (K)

Natal Comforts, The Cotswolds, United Kingdom.

Alexander E P Heazell (AEP)

Division of Developmental Biology and Medicine, Maternal and Fetal Health Research Centre, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.
Saint Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, University of Manchester, Manchester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH